Pilot study: Peripheral biomarkers for diagnosing sporadic Parkinson's disease

Journal of Neural Transmission

Volumn 117, Issue 12, 2010, Pages 1387-1393

  Grünblatt, Edna ^a,e   Zehetmayer, Sonja ^b   Jacob, Christian P ^a   Müller, Thomas ^c   Jost, Wolfgang H ^d   Riederer, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c St Joseph Hospital   (Germany)

^d DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aldehyde dehydrogenase 1 family, member A1 (ALDH1A1); Biomarker; Blood; Diagnose diagnosis; Gene expression; Histone cluster 1, H3E (HIST1H3E); Laminin beta 2 (LAMB2); mRNA, Parkinson's disease (PD); Proteasome (prosome, macropain) subunit, alpha type, 2 (PSMA2); Transcriptome

Indexed keywords

ALDEHYDE DEHYDROGENASE; HISTONE H3; LAMININ; PROTEASOME; RNA;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BLOOD SAMPLING; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 78651237174     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0509-1     Document Type: Article

References (42)

1. L Berg 1988 Clinical Dementia Rating (CDR) Psychopharmacol Bull 24 637 639 1:STN:280:DyaL1M3msFCitA%3D%3D 3249765
2. H Bernheimer W Birkmayer O Hornykiewicz K Jellinger F Seitelberger 1973 Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 415 455 1:CAS:528:DyaE28XlvFSgt7k%3D 4272516
3. R Bhidayasiri 2006 How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease? Rev Neurol Dis 3 19 22 16596082
4. M Bogdanov WR Matson L Wang T Matson R Saunders-Pullman SS Bressman MF Beal 2008 Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain 131 389 396 18222993
5. DJ Brooks 1998 The early diagnosis of Parkinson's disease Ann Neurol 44 S10 S18 1:STN:280:DyaK1cvhvF2qug%3D%3D 9749569
6. J Coste L Ouchchane L Sarry P Derost F Durif J Gabrillargues S Hemm JJ Lemaire 2009 New electrophysiological mapping combined with MRI in parkinsonian's subthalamic region Eur J Neurosci 29 1627 1633 1:STN:280:DC%2BD1Mzis1Witw%3D%3D 19419425
7. J Eerola PJ Tienari S Kaakkola P Nikkinen J Launes 2005 How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry 76 1211 1216 1:STN:280:DC%2BD2MvktV2nsA%3D%3D 16107353
8. Fahn S, Elton R, Committee, Mot UD (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan, New York, pp 153-167
9. M Fasano T Alberio L Lopiano 2008 Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration Biomarkers Med 2 465 478 1:CAS:528:DC%2BD1cXhtlKmtLfN
10. E Grünblatt 2008 Commonalities in the genetics of Alzheimer's disease and Parkinson's disease Expert Rev Neurother 8 1865 1877 19086884
11. E Grünblatt S Mandel J Jacob-Hirsch, et al. 2004 Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes J Neural Transm 111 1543 1573 15455214
12. E Grünblatt N Zander J Bartl, et al. 2007 Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease J Alzheimers Dis 12 291 311 18198416
13. E Grünblatt J Bartl S Zehetmayer TM Ringel P Bauer P Riederer CP Jacob 2009 Gene expression as peripheral biomarkers for sporadic Alzheimer's disease J Alzheimers Dis 16 627 634 19276557
14. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 1:STN:280:DyaF3c7ltFyksw%3D%3D 14399272
15. T Hatano S Kubo S Sato N Hattori 2009 Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease J Neurochem 111 1075 1093 1:CAS:528:DC%2BD1MXhsVyrsbbK 19780902
16. MA Hauser YJ Li H Xu, et al. 2005 Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism Arch Neurol 62 917 921 15956162
17. G Hennecke CR Scherzer 2008 RNA biomarkers of Parkinson's disease: developing tools for novel therapies Biomarkers Med 2 41 53 1:CAS:528: DC%2BD1cXht1SitLg%3D
18. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
19. AJ Hughes SE Daniel Y Ben-Shlomo AJ Lees 2002 The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 861 870 11912118
20. MJ Hurley DC Mash P Jenner 2003 Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR Eur J Neurosci 18 2668 2672 14622169
21. J Jankovic AH Rajput MP McDermott DP Perl 2000 The evolution of diagnosis in early Parkinson disease. Parkinson Study Group Arch Neurol 57 369 372 1:STN:280:DC%2BD3c7nslWntw%3D%3D 10714663
22. M Kassiou R Banati RM Holsinger S Meikle 2009 Challenges in molecular imaging of Parkinson's disease: a brief overview Brain Res Bull 78 105 108 1:CAS:528:DC%2BD1MXhtFSmtrg%3D 18790022
23. C Klein SA Schneider AE Lang 2009 Hereditary parkinsonism: Parkinson disease look-alikes-an algorithm for clinicians to "PARK" genes and beyond Mov Disord 24 2042 2058 19735092
24. J Koerts KL Leenders M Koning AT Portman M van Beilen 2007 Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease Eur J Neurosci 25 3132 3136 17561826
25. L Lovrecic A Kastrin J Kobal Z Pirtosek D Krainc B Peterlin 2009 Gene expression changes in blood as a putative biomarker for Huntington's disease Mov Disord 24 2277 2281 19844910
26. L Lu F Neff D Alvarez-Fischer C Henze Y Xie WH Oertel J Schlegel A Hartmann 2005 Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease Exp Neurol 195 27 39 1:CAS:528:DC%2BD2MXnslygs7k%3D 15944136
27. T Manolio 2003 Novel risk markers and clinical practice N Engl J Med 349 1587 1589 1:CAS:528:DC%2BD3sXosFWktLo%3D 14573728
28. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 939 944 1:STN:280:DyaL2c3ks1altQ%3D%3D 6610841
29. AW Michell SJG Lewis T Foltynie RA Barker 2004 Biomarkers and Parkinson's disease Brain 127 1693 1705 1:STN:280:DC%2BD2cznt1Crsw%3D%3D 15215212
30. B Mollenhauer C Trenkwalder 2009 Neurochemical biomarkers in the differential diagnosis of movement disorders Mov Disord 24 1411 1426 19412961
31. DW O'Connor PA Pollitt JB Hyde JL Fellows ND Miller CP Brook BB Reiss 1989 The reliability and validity of the mini-mental state in a British community survey J Psychiatr Res 23 87 96 2666647
32. JS Paulsen 2009 Biomarkers to predict and track diseases Lancet Neurol 8 776 777 19646925
33. RB Postuma J Montplaisir 2006 Potential early markers of Parkinson's disease in idiopathic rapid-eye-movement sleep behaviour disorder Lancet Neurol 5 552 553 16781982 (Pubitemid 43867428)
34. B Ravina C Tanner D Dieuliis, et al. 2009 A longitudinal program for biomarker development in Parkinson's disease: a feasibility study Mov Disord 24 2081 2090 19691116
35. CR Scherzer 2009 Chipping away at diagnostics for neurodegenerative diseases Neurobiol Dis 35 148 156 1:CAS:528:DC%2BD1MXotFCgtrg%3D 19285134
36. CR Scherzer AC Eklund LJ Morse, et al. 2007 Molecular markers of early Parkinson's disease based on gene expression in blood Proc Natl Acad Sci USA 104 955 960 1:CAS:528:DC%2BD2sXhtVSjtr4%3D 17215369
37. F Simunovic M Yi YL Wang, et al. 2009 Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology Brain 132 1795 1809 19052140
38. PF Sullivan C Fan CM Perou 2006 Evaluating the comparability of gene expression in blood and brain Am J Med Genet B Neuropsychiatr Genet 141 261 268
39. E Tolosa G Wenning W Poewe 2006 The diagnosis of Parkinson's disease Lancet Neurol 5 75 86 16361025
40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7):research0034.1-research0034.11
41. Wouters H, van Gool WA, Schmand B, Lindeboom R (2008) Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 22(3):236-244
42. Y Zhang M James FA Middleton RL Davis 2005 Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms Am J Med Genet B Neuropsychiatr Genet 137 5 16